Literature DB >> 19493020

Age-dependent increase of FVIII:C in mild haemophilia A.

W Miesbach1, S Alesci, S Krekeler, E Seifried.   

Abstract

Variability of FVIII:C levels in healthy individuals and age-dependent increase are a known phenomenon. In haemophilia, increasing FVIII:C levels with age have not been described yet. In our study, we evaluated this issue retrospectively in a cohort older than 45 years of 29 patients with mild haemophilia and 14 patients with moderate or severe haemophilia at last visit at the haemophilia centre Frankfurt. The median duration of observation evaluated in this study was 17 years (range 5-28). Results show a significant correlation of increasing FVIII:C levels with age in mild haemophilia (P = 0.000041) and a non-significant tendency to a higher increase in higher age (P = 0.085652). The median difference of FVIII:C level between the first and last measurement was 8% of normal plasma concentration (range -3% to +35%). Median FVIII:C level increase of patients younger than 62 years was 7.5% (range -3 to 22), median increase in older patients was 12% (range 0-35). This tendency could not be correlated to decreased number of bleedings, but FVIII substitution dosage should be adapted to changing plasma levels at higher age to prevent overdosing or thrombotic risks. Possible causes and contributing factors for increasing FVIII:C levels are discussed. Statistical significance remains to be confirmed in larger prospective studies also including younger patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19493020     DOI: 10.1111/j.1365-2516.2009.02051.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  3 in total

1.  Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease.

Authors:  N Rydz; J Grabell; D Lillicrap; P D James
Journal:  Haemophilia       Date:  2015-03-10       Impact factor: 4.287

2.  Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non-severe haemophilia A.

Authors:  Judit Rejtő; Oliver Königsbrügge; Ella Grilz; Stefanie Hofer; Lisa-Marie Mauracher; Cornelia Gabler; Gerhard Schuster; Clemens Feistritzer; Raute Sunder-Plaßmann; Peter Quehenberger; Johanna Gebhart; Cihan Ay; Ingrid Pabinger
Journal:  J Thromb Haemost       Date:  2020-03-20       Impact factor: 5.824

Review 3.  Prevalence of symptoms in hemophilia carriers in comparison with the general population: a systematic review.

Authors:  André Bubna Hirayama; Alline Karolyne Cândida da Silva; Jordanna Sousa Rocha; Maria do Rosário Ferraz Roberti
Journal:  Hematol Transfus Cell Ther       Date:  2019-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.